Eugene Regis

Title: The Innovations of Eugene Regis

Introduction

Eugene Regis is a notable inventor based in Freeport, ME (US). He has made significant contributions to the field of veterinary medicine, particularly through his work on feline pancreatic lipase. His innovative approach has led to advancements in the detection and quantification of this important enzyme in biological samples.

Latest Patents

Eugene Regis holds a patent for "Feline pancreatic lipase - Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof." This patent encompasses isolated feline pancreatic lipase polypeptides, methods for expressing these polypeptides, and the generation of monoclonal antibodies that specifically bind to them. Additionally, it includes methods for determining the presence or amount of feline pancreatic lipase in biological samples, utilizing standards or calibrators of recombinant feline pancreatic lipase. The patent also covers devices and kits designed for detecting feline pancreatic lipase in biological samples.

Career Highlights

Eugene Regis is currently associated with IDEXX Laboratories, Inc., a company renowned for its innovations in veterinary diagnostics. His work has contributed to the development of more effective diagnostic tools for veterinarians, enhancing the care provided to feline patients.

Collaborations

Throughout his career, Eugene has collaborated with esteemed colleagues such as Philip R Andersen and Melissa Jane Beall. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Eugene Regis exemplifies the spirit of innovation in veterinary medicine through his groundbreaking work on feline pancreatic lipase. His contributions have paved the way for improved diagnostic methods, ultimately benefiting the health and well-being of cats.